diclofenac potassium
Generic: diclofenac potassium
Labeler: leading pharma, llcDrug Facts
Product Profile
Brand Name
diclofenac potassium
Generic Name
diclofenac potassium
Labeler
leading pharma, llc
Dosage Form
POWDER, FOR SOLUTION
Routes
Active Ingredients
diclofenac potassium 50 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
69315-506
Product ID
69315-506_9c24af27-0a21-4fb7-a8fb-55c92373b852
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA AUTHORIZED GENERIC
Application Number
NDA022165
Listing Expiration
2026-12-31
Marketing Start
2022-12-20
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
69315506
Hyphenated Format
69315-506
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
diclofenac potassium (source: ndc)
Generic Name
diclofenac potassium (source: ndc)
Application Number
NDA022165 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 50 mg/1
Packaging
- 9 PACKET in 1 CARTON (69315-506-09) / 1 POWDER, FOR SOLUTION in 1 PACKET
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "9c24af27-0a21-4fb7-a8fb-55c92373b852", "openfda": {"unii": ["L4D5UA6CB4"], "rxcui": ["859063"], "spl_set_id": ["9dd418b2-4b0e-498c-b453-f580c69ddc6d"], "manufacturer_name": ["Leading Pharma, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "9 PACKET in 1 CARTON (69315-506-09) / 1 POWDER, FOR SOLUTION in 1 PACKET", "package_ndc": "69315-506-09", "marketing_start_date": "20221220"}], "brand_name": "DICLOFENAC POTASSIUM", "product_id": "69315-506_9c24af27-0a21-4fb7-a8fb-55c92373b852", "dosage_form": "POWDER, FOR SOLUTION", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "69315-506", "generic_name": "DICLOFENAC POTASSIUM", "labeler_name": "Leading Pharma, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "DICLOFENAC POTASSIUM", "active_ingredients": [{"name": "DICLOFENAC POTASSIUM", "strength": "50 mg/1"}], "application_number": "NDA022165", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20221220", "listing_expiration_date": "20261231"}